Live Online Carcinoid Syndrome Program for Patients and Caregivers

June 14, 2018
Register Today and Ask Your Questions for the June 20, 2018 Online Education Program on Carcinoid Syndrome! http://www.cancercoachlive.com/landing-page-carcinoid-syndrome/ Sign Up for the On Demand Program If You Can’t Join Us Next Week… READ MORE
Carcinoid Syndrome, Live Online Event, June 2018, Dr. David Metz, Bonnie Bennett

Patient & Caregiver Education on Carcinoid Syndrome: Talking to Your Doctor About Symptoms, Diet, and Treatment

June 5, 2018
A  Free, Live Online Event on Wednesday, June 20, 3:00-4:00 pm EST Click Here to Register

 

Last Spring, we were pleased to create an interactive resource for people living with Carcinoid Syndrome with our partner CancerCoachLive – we’ve teamed…

READ MORE
Steve Mazan, Laugh and Learn, June 2018

Laugh and Learn with Comedian Steve Mazan

May 30, 2018

Come and laugh with Steve Mazan, stand-up comedian, inspirational speaker, and 13-year NET cancer survivor. “CS Happens” is a Laugh and Learn special evening for the NET community, and is complementary courtesy of Lexicon Pharmaceuticals. This…

READ MORE

Endocrinology Society Recognizes Neuroendocrine Cancer Physician and Researcher for Excellence at 2018 Annual Meeting

April 15, 2018

When Amit Tirosh, MD came to the United States in 2015 to be a senior endocrinologist at the National Institutes of Health (NIH), he began a journey that will lead full circle when he returns to Israel this summer to establish and lead a new neuroendocrine

READ MORE
Edward Wolin, MD joins Markey Cancer Center as Director of the Carcinoid and Neuroendocrine Tumor Program

June Luncheon with the Experts in New York City for the Neuroendocrine Tumor Community

April 3, 2018

Join neuroendocrine tumor (NET) patients in New York City on Sunday, June 10, 2018 for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues ranging…

READ MORE

PRRT – FDA Approves Lutathera®, What’s Next?

February 20, 2018

The FDA approval of Lutathera®, a peptide receptor radionuclide therapy (PRRT), on January 26, 2018 signals a new era in treatment options for the neuroendocrine cancer community.  It has also raised a host of questions including:

  • What exactly is
READ MORE

Zebra Tales: Carcinoid NETs Health Storylines Launches New Feature

February 15, 2018

Carcinoid NETs Health Storylines presents Zebra Tales! This brand new feature enables you to learn and share more about the experiences of others within the neuroendocrine tumor (NET) community.

Our first inspiring story is from Stacie Chevrier –…

READ MORE

FDA Approves LUTATHERA® for Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

January 26, 2018

BREAKING NEWS: On January 26, 2018 the US Food and Drug Administration approved LUTATHERA® marking the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of gastroenteropancreatic neuroendocrine tumors

READ MORE

News about Neuroendocrine Cancer Expert Physicians

January 8, 2018

Three appointments and a newly established one-year neuroendocrine tumor (NET) fellowship herald an exciting new year for several NET specialists.

Dr. Edward M. Wolin

Edward M. Wolin, MD, Co-Medical Director of the Carcinoid Cancer Foundation, has…

READ MORE
The late Monica Warner, a pioneer in carciniod and NET cancer patient advocacy

8th Annual Warner Advocacy Award: Call for Nominations

November 14, 2017

Novartis Oncology and The NET Alliance have announced that nominations are open for the 8th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize…

READ MORE